110 related articles for article (PubMed ID: 7438075)
1. An in vitro assay procedure to test chemotherapeutic drugs on cells from human solid tumors.
Shrivastav S; Bonar RA; Stone KR; Paulson DF
Cancer Res; 1980 Dec; 40(12):4438-42. PubMed ID: 7438075
[TBL] [Abstract][Full Text] [Related]
2. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of human tumor clonogenic and nude mouse-isotope assays in anticancer-agent sensitivity tests].
Hirabayashi N; Nosoh Y; Nishiyama M; Yamaguchi M; Yoshinaka K; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1808-12. PubMed ID: 3929691
[TBL] [Abstract][Full Text] [Related]
4. An in vitro method for testing the sensitivities to drugs of human osteosarcomas grafted onto nude mice.
Ishii S; Yamawaki S; Sasaki T; Usui M; Ubayama Y; Minami A; Yagi T; Isu K; Kobayashi M
Clin Orthop Relat Res; 1983; (172):281-8. PubMed ID: 6401609
[TBL] [Abstract][Full Text] [Related]
5. Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agents.
Aamdal S; Fodstad O; Pihl A
Anticancer Res; 1985; 5(4):329-37. PubMed ID: 4037730
[TBL] [Abstract][Full Text] [Related]
6. Human tumor testsystems: a new screening approach.
Kraemer HP; Sedlacek HH
Behring Inst Mitt; 1986 Jun; (80):103-12. PubMed ID: 3753367
[TBL] [Abstract][Full Text] [Related]
7. Murine pulmonary adenoma bioassay of potentially effective agents against slow-growing solid tumors.
Theiss JC; Stoner GD; Shimkin MB
Cancer Res; 1977 Jan; 37(1):305-9. PubMed ID: 830416
[TBL] [Abstract][Full Text] [Related]
8. Activation of cyclophosphamide for in vitro testing of cell sensitivity.
Shrivastav S; Stone KR; Paulson DF; Bonar RA
Cancer Res; 1980 Dec; 40(12):4443-5. PubMed ID: 7438076
[TBL] [Abstract][Full Text] [Related]
9. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
[TBL] [Abstract][Full Text] [Related]
10. Androgen-dependent and -independent human prostate xenograft tumors as models for drug activity evaluation.
Chen CT; Gan Y; Au JL; Wientjes MG
Cancer Res; 1998 Jul; 58(13):2777-83. PubMed ID: 9661891
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of chemosensitivity in the 6-day subrenal capsule assay].
Inoue K
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2423-30. PubMed ID: 3619455
[TBL] [Abstract][Full Text] [Related]
12. Prostate carcinoma response to cytotoxic therapy: in vivo resistance.
Teicher BA; Kakeji Y; Ara G; Herbst RS; Northey D
In Vivo; 1997; 11(6):453-61. PubMed ID: 9509295
[TBL] [Abstract][Full Text] [Related]
13. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
Cook JL; Miura TA; Iklé DN; Lewis AM; Routes JM
Cancer Res; 2003 Jun; 63(12):3435-43. PubMed ID: 12810682
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumors.
Richardson F; Black C; Richardson K; Franks A; Wells E; Karimi S; Sennello G; Hart K; Meyer D; Emerson D; Brown E; LeRay J; Nilsson C; Tomkinson B; Bendele R
Cancer Chemother Pharmacol; 2005 Mar; 55(3):213-21. PubMed ID: 15592840
[TBL] [Abstract][Full Text] [Related]
15. A modified screening system to select new cytostatic drugs.
Kraemer HP; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326
[No Abstract] [Full Text] [Related]
16. [Responsiveness of brain tumors to chemotherapeutic agents in the subrenal capsule assay].
Yamada K; Itoh S; Saitoh S; Nakai O; Wechsler W
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1241-8. PubMed ID: 3729448
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo preclinical chemotherapy studies of human neuroblastoma.
Siegel MM; Chung HS; Rucker N; Siegel SE; Seeger RC; Isaacs H; Benedict WF
Cancer Treat Rep; 1980; 64(8-9):975-9. PubMed ID: 7448832
[TBL] [Abstract][Full Text] [Related]
19. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
Qin Y; Ertl T; Cai RZ; Halmos G; Schally AV
Cancer Res; 1994 Feb; 54(4):1035-41. PubMed ID: 8313359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
